SLC2A5 and cancer: In this manuscript, we summarize our pilot studies on exploring the feasibility of transporting a bioactive agent through GLUT5 and achieving cancer-specific cytotoxicity due to the differences in the presence of GLUT5 in cancer vs. normal cells.